Third Harmonic Bio Inc (THRD)
11.70
+0.11
(+0.95%)
USD |
NASDAQ |
May 03, 16:00
11.70
0.00 (0.00%)
After-Hours: 20:00
Third Harmonic Bio Enterprise Value: 207.78M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 207.78M |
| May 02, 2024 | 203.30M |
| May 01, 2024 | 194.74M |
| April 30, 2024 | 184.96M |
| April 29, 2024 | 185.37M |
| April 26, 2024 | 172.33M |
| April 25, 2024 | 157.25M |
| April 24, 2024 | 192.70M |
| April 23, 2024 | 181.29M |
| April 22, 2024 | 205.75M |
| April 19, 2024 | 206.97M |
| April 18, 2024 | 196.78M |
| April 17, 2024 | 190.67M |
| April 16, 2024 | 203.30M |
| April 15, 2024 | 211.45M |
| April 12, 2024 | 200.45M |
| April 11, 2024 | 219.20M |
| April 10, 2024 | 217.06M |
| April 09, 2024 | 182.05M |
| April 08, 2024 | 174.72M |
| April 05, 2024 | 166.57M |
| April 04, 2024 | 142.15M |
| April 03, 2024 | 109.98M |
| April 02, 2024 | 86.77M |
| April 01, 2024 | 87.18M |
| Date | Value |
|---|---|
| March 28, 2024 | 115.27M |
| March 27, 2024 | 116.50M |
| March 26, 2024 | 96.55M |
| March 25, 2024 | 88.00M |
| March 22, 2024 | 81.07M |
| March 21, 2024 | 105.11M |
| March 20, 2024 | 102.30M |
| March 19, 2024 | 96.29M |
| March 18, 2024 | 93.08M |
| March 15, 2024 | 105.91M |
| March 14, 2024 | 96.69M |
| March 13, 2024 | 117.54M |
| March 12, 2024 | 117.54M |
| March 11, 2024 | 132.38M |
| March 08, 2024 | 130.78M |
| March 07, 2024 | 131.98M |
| March 06, 2024 | 131.58M |
| March 05, 2024 | 121.95M |
| March 04, 2024 | 128.37M |
| March 01, 2024 | 144.01M |
| February 29, 2024 | 137.59M |
| February 28, 2024 | 141.20M |
| February 27, 2024 | 130.78M |
| February 26, 2024 | 137.59M |
| February 23, 2024 | 139.60M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-137.34M
Minimum
Dec 20 2022
691.02M
Maximum
Sep 27 2022
73.10M
Average
-12.03M
Median
Aug 23 2023
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.813M |
| Palatin Technologies Inc | 24.56M |
| iBio Inc | 16.80M |
| Theriva Biologics Inc | -13.31M |
| Oragenics Inc | 3.216M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.836M |
| Total Expenses (Quarterly) | 10.40M |
| EPS Diluted (Quarterly) | -0.17 |
| Earnings Yield | -8.12% |